OPIS
Desconocido
Solnatide: Exploration of safety tolerability and clinical efficacy of Solnatide IMP in patients infected with...
OPIS SRL
participó en un
H2020:
H2020-SC1-PHE-CORONAVIRUS-2020
Clinical features of patients infected with the 2019-nCoV have revealed that these patients suffer from severe respiratory failure, and pres...
2020-03-30 - 2022-06-30 | Financiado
2020-03-30 - 2022-06-30 | Financiado
* No se disponen de datos de la empresa actual.